Skip to main content

McKesson Ventures, LLC's Form 4/A amendment

Amended

Augmedix, Inc. (AUGX) · filed Sep 20, 2022

Accession no.
0001062993-22-019796
Filed
Sep 20, 2022
Trade date
Oct 28, 2021
Filing delay
327 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Nov 1, 2021

This filing lists 1 non-derivative transaction. Open-market purchases total $450.0K. It was filed 327 days after the trade.

This amendment replaces 0001213900-21-055921 (filed Nov 1, 2021).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
McKesson Ventures, LLCCIK 0001827312Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 28, 2021Common StockPPurchaseAcquired+112,500$4.00+$450,0004,047,606Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

These securities are held of record by McKesson Ventures LLC ("McKesson"). Jennifer M. Carter, a member of the Issuer's board of directors, is an executive vice president and chief strategy and business development officer at McKesson. As a result, McKesson is a director by deputization for Section 16 purposes.

Remarks

This amendment is being filed to amend the original Form 4 filed on November 1, 2021 (the "Original Form 4") to correct the amount of securities acquired in Column 4 of Table I and amount of securities beneficially owned in Column 5 of Table I which were inadvertently incorrectly reported in the Original Form 4. All other information in the Original Form 4 remains unchanged.

Read the full filing on SEC EDGAR (opens in a new tab)